These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2901554)

  • 1. Urokinase versus tissue plasminogen activator in pulmonary embolism.
    Lancet; 1988 Sep; 2(8612):691-2. PubMed ID: 2901554
    [No Abstract]   [Full Text] [Related]  

  • 2. TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial.
    Goldhaber SZ
    Vasa Suppl; 1989; 27():292-4. PubMed ID: 2516368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tissue plasminogen activator after resuscitation in fulminant pulmonary embolism].
    Böttiger BW
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1528-9. PubMed ID: 7588025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of pulmonary thromboembolism].
    Nagata H; Kawakami Y
    Kokyu To Junkan; 1989 Sep; 37(9):961-5. PubMed ID: 2512601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term thrombolytic therapy in pulmonary artery embolism with rt-PA].
    Stark G; Pilger E; Smolle H; Sterz F; Decrinis M; Obernosterer A; Aschauer M; Flückiger F; Lafer M; Pieber D
    Vasa Suppl; 1991; 33():126. PubMed ID: 1788641
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of acute cerebral infarction with urokinase and tissue plasminogen activator].
    Araki G
    Nihon Rinsho; 1993 Nov; 51 Suppl():449-57. PubMed ID: 8283700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Low dosage fibrinolytic therapy with r-TPA in thromboses of the deep venous system].
    Hagg NB
    Vasa Suppl; 1991; 33():124-5. PubMed ID: 1788640
    [No Abstract]   [Full Text] [Related]  

  • 10. Modern treatment of pulmonary embolism.
    Kessler CM
    Lung; 1990; 168 Suppl():841-8. PubMed ID: 2117202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of pulmonary embolism].
    Mörl H
    Dtsch Med Wochenschr; 1978 Mar; 103(13):541-2. PubMed ID: 639683
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis for life-threatening pulmonary embolism 2 days after lung resection.
    Girard P; Baldeyrou P; Le Guillou JL; Lamer C; Grunenwald D
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1595-7. PubMed ID: 8503574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V
    Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
    [No Abstract]   [Full Text] [Related]  

  • 15. [On-the-table lysis compared with overnight lysis in acute and subacute occlusions of peripheral arteries and bypasses].
    Rinast E; Zwaan M; Kummer-Kloess D; Weiss HD
    Vasa Suppl; 1992; 35():186. PubMed ID: 1481040
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of acute and chronic pulmonary thromboembolism].
    Hiraoka N; Fujioka H; Nakano T
    Kokyu To Junkan; 1993 Sep; 41(9):829-33. PubMed ID: 8210740
    [No Abstract]   [Full Text] [Related]  

  • 18. Urokinase versus tissue plasminogen activator in pulmonary embolism.
    Goldhaber SZ; Loscalzo J
    Lancet; 1988 Oct; 2(8616):915. PubMed ID: 2902375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.